Results 11 to 20 of about 37,055 (199)
Resveratrol attenuates moxifloxacin-induced oxidative damage in the liver, kidneys, brain, and serum of Wistar rats [PDF]
Journal of International Medical ResearchObjective Moxifloxacin, a widely used fluoroquinolone, has been associated with oxidative stress and tissue injury. Resveratrol may attenuate oxidative damage.
Gülfem Yıldırım, Ayşen Çakır
doaj +2 more sources
Moxifloxacin-induced neutropenia in 26-year-old man [PDF]
Journal of Infection in Developing Countries, 2018 Moxifloxacin is a fourth generation widely used fluoroquinolone antibiotic. There are three cases of moxifloxacin-induced neutropenia reported in the literature and we report the fourth case.
Tuğba Kula Atik +6 more
doaj +2 more sources
HERG Protein Plays a Role in Moxifloxacin-Induced Hypoglycemia [PDF]
Journal of Diabetes Research, 2016 The purpose of this study was to investigate the effect of moxifloxacin on HERG channel protein and glucose metabolism. HERG expression was investigated using immunohistochemistry.
Hai-Yan Qiu +4 more
doaj +2 more sources
Case Report: Drug-induced pneumonia caused by moxifloxacin and a literature review [PDF]
Frontiers in MedicineDrug-induced pneumonia is a rare and potentially life-threatening adverse drug reaction. Moxifloxacin is a fluoroquinolone antibiotic with broad-spectrum antimicrobial activity.
Zhan Gao +6 more
doaj +2 more sources
Cohort Study of Intracameral Moxifloxacin in Postoperative Endophthalmitis Prophylaxis
Ophthalmology and Eye Diseases, 2014 We conducted a cohort study to evaluate post-cataract surgery endophthalmitis rates in relation to prophylactic intracameral moxifloxacin administration.
Virgilio Galvis +3 more
doaj +2 more sources
Immunomodulatory Effects and Protection in Sepsis by the Antibiotic Moxifloxacin [PDF]
AntibioticsSepsis is a leading cause of death in Intensive Care Units. Despite its prevalence, sepsis remains insufficiently understood, with no substantial qualitative improvements in its treatment in the past decades.
Tiago R. Velho +7 more
doaj +2 more sources
Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
Emerging Infectious Diseases, 2015 Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB–positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because ...
Lisa Trieu +2 more
doaj +2 more sources
Decreased protein binding of moxifloxacin in patients with sepsis?
GMS Infectious Diseases, 2017 The mean (SD) unbound fraction of moxifloxacin in plasma from patients with severe sepsis or septic shock was determined by ultrafiltration to 85.5±3.0% (range 81.9 and 91.6%) indicating a decreased protein binding of moxifloxacin in this population ...
Dorn, Christoph +6 more
doaj +2 more sources
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis [PDF]
, 2015 Supported by the Global Alliance for TB Drug Development with support from the Bill and Melinda Gates Foundation, the European and Developing Countries Clinical Trials Partnership, U.S. Agency for International Development, U.K.
for the REMoxTB Consortium +9 more
core +3 more sources
Periodontology 2000, EarlyView., 2023 Abstract This narrative review summarizes the collective knowledge on periodontal microbiology, through a historical timeline that highlights the European contribution in the global field. The etiological concepts on periodontal disease culminate to the ecological plaque hypothesis and its dysbiosis‐centered interpretation.
Georgios N. Belibasakis +5 more
wiley +1 more source